Suppr超能文献

在下肢血管腔内血管重建术中联合使用评分法和西罗莫司药物涂层球囊治疗慢性肢体威胁性缺血:病例系列

Combination therapy using scoring and sirolimus drug-coated balloons during lower limb endovascular revascularization for chronic limb threatening ischaemia: A case series.

作者信息

Bong Tiffany Sh, Yap Charyl Jq, Soon Shereen Xy, Tang Tjun Y

机构信息

Department of Vascular Surgery, Singapore General Hospital, Singapore.

Duke-NUS Graduate Medical School, Singapore.

出版信息

SAGE Open Med Case Rep. 2022 Mar 17;10:2050313X221085859. doi: 10.1177/2050313X221085859. eCollection 2022.

Abstract

The aim of this case series was to document our early experience using combination therapy with ™ percutaneous transluminal angioplasty balloon (BD Interventional, New Jersey, US) and ™ (M.A. MedAlliance SA, Nyon, Switzerland) sirolimus-coated balloon catheter for anti-restenotic drug elution, in the setting of multifocal high-grade stenosis for chronic limb threatening ischaemia. Our anecdotal experience was that preparing the lesion with scoring balloon and then using sirolimus drug-eluting balloon may have synergistic effect when used in tandem, especially in the setting of calcified arterial lesions, where the scoring wires may achieve deeper clefts within the atheromatous plaque to allow better drug absorption into the arterial wall. We report two cases with high-grade multifocal stenosis affecting the superficial femoral and anterior tibial arteries, respectively. Combination therapy using the scoring balloon to first prepare the lesion followed by sirolimus elution achieved technical and procedural success in both cases and a 100% 30-day primary patency. There were no complications related to flow-limiting dissections, vessel perforation or acute recoil. However, whether this combination therapy leads to better primary vessel patency with longer freedom from target lesion revascularization in the medium term remains to be determined.

摘要

本病例系列的目的是记录我们在慢性肢体威胁性缺血的多灶性重度狭窄情况下,使用经皮腔内血管成形术球囊(美国新泽西州BD介入公司)和西罗莫司涂层球囊导管(瑞士尼永M.A. MedAlliance SA公司)联合治疗进行抗再狭窄药物洗脱的早期经验。我们的经验是,先用刻痕球囊预处理病变,然后使用西罗莫司药物洗脱球囊,串联使用时可能具有协同作用,特别是在钙化动脉病变的情况下,刻痕导丝可在动脉粥样硬化斑块内形成更深的裂隙,以便药物更好地吸收进入动脉壁。我们报告了两例分别累及股浅动脉和胫前动脉的多灶性重度狭窄病例。在这两例病例中,先用刻痕球囊预处理病变,然后进行西罗莫司洗脱的联合治疗均取得了技术和操作上的成功,30天的初次通畅率为100%。没有与血流限制性夹层、血管穿孔或急性回缩相关的并发症。然而,这种联合治疗是否能在中期带来更好的原发血管通畅率以及更长时间的免于靶病变血运重建,仍有待确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eeb8/8935410/e5c183aa5348/10.1177_2050313X221085859-fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验